Status:
UNKNOWN
NeuroGlove PTSD Study
Lead Sponsor:
NeuroGlove LLC
Conditions:
PTSD
Post Traumatic Stress Disorder
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This is a prospective, home-based, interventional clinical study in which 6 subjects will be enrolled. Six (6) subjects who suffer from post-traumatic stress disorder will receive treatment using the ...
Detailed Description
This is a prospective, home-based, interventional clinical study in which 6 subjects will be enrolled. Six (6) subjects who suffer from post-traumatic stress disorder will receive treatment using the ...
Eligibility Criteria
Inclusion
- Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject.
- Men and women ≥18 and \<85 years of age.
- Carry an active diagnosis of PTSD.
- Suffer from PTSD symptoms that impact subject's daily activities and quality of life.
Exclusion
- Physical limitations of the upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)
- Subject lacks the ability to comprehend or following instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.
- Currently participating in another interventional clinical trial. (Observational clinical trial participation is allowed for study enrollment.)
Key Trial Info
Start Date :
August 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT06050590
Start Date
August 14 2023
End Date
September 1 2024
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NeuroGlove
Saint Paul, Minnesota, United States, 55102